***************************************************************************************************************************************************************************************************************************************
Stony Brook Launches "An Idea Can Do Anything"
 Stony Brook University newly launched multimedia advertising campaign includes a two minute documentary film that features Center for Biotechnology Director Dr. Clinton Rubin. The campaign, based around the concept of “An idea can do anything”, was created to raise awareness of Stony Brook Medicine’s role in providing high-quality patient care, renowned medical research and healthcare education as Long Island’s premier academic medical institution.
Stony Brook Medicine is the new, unifying brand that integrates all of Stony Brook University’s health-related initiatives. View the 2 minute documentary film and other campaign materials at www.stonybrookmedicine.edu/idea.
***************************************************************************************************************************************************************************************************************************************
Advisory Board to Lead New CFB Initiatives
If you, or someone you care about, has been treated for coronary disease, screened for colon cancer, or used a certain brand-named toothpaste, it is likely you’ve been touched by technology developed with the support of Stony Brook University’s Center for Biotechnology. Along with technologies that accelerate fracture healing or can detect single metastatic cancer cells in human blood, the Center has influenced the successful development of Xiaflex™, ReoPro™, Periostat®, Cavistat®, V3D Colon™ virtual colonoscopy, Exogen™ Bone Healing System, Two-Hybrid Technology, among others.
To begin to capture some of the economic impact related to these innovations locally, the CFB will establish an Advisory Board comprised of thought leaders committed to developing a bioscience industry cluster in the Long Island region. “There are significant challenges inherent in launching bioscience companies here, and a limited pool of experienced bioentrepreneurs and access to capital are at the top of the list,” said Diane Fabel, Director of Operations for the Center. “Our initial focus will be on ‘de-risking’ technologies that can support company formation, and launching a pilot entrepreneur-in-residence initiative to move them toward commercialization. If we can focus our resources on jump-starting a handful of professionally managed and financed companies, we may have the beginnings of a cluster."
To learn more please contact Diane Fabel, Director of Operations at 631.632.8521
***************************************************************************************************************************************************************************************************************************************
CFB Assistant Director Published in Touro Law Review
CFB Assistant Director for Technology Commercialization, Michael R. Bielski recently authored an article published in the Touro Law Review. “Strict interpretation of 35 U.S.C. § 112: requires universities to examine their patenting methods” Co-authored by Sharon Barkume, IP Manager at Sound Interventions and Associate at Barkume and Associated, P.C. Since university inventions often result in fundamental patents where the commercial applications of the invention is not yet fully understood, the article explores how an understanding of recent court holdings that require an increase in the quantity and quality of information disclosed in a patent can be used to build stronger university patents that will enable more efficient technology transfer mechanisms. View complete article.
****************************************************************************************************************************************************************************************************************************************
2012 Long Island Innovation Boot Camp/Pre-Seed Workshop
The 2012 Long Island Innovation Boot Camp/Pre-Seed Workshop was held on March 7, 8 and 15 at the Garden City Hotel and the Center for Excellence in Wireless and Information Technology (CEWIT) at Stony Brook University. This intense, 2 ½ day workshop was organized to help evaluate and transform potentially commercializable technologies into pre-seed stage companies. More than 70 experts from the bioscience, information technology and clean energy industries participated across 8 teams, along with representatives from the investment community, academia, professional service providers and business school students. These team members assisted in evaluating technologies selected from the medical biotechnology, IT and clean energy sectors to develop a thin commercialization plan presented to prospective investors at the conclusion of the event. Technologies included:
· Next generation of Positron Emission Tomography (PET) Scanners which have superior imaging capabilities to what is currently available in the pre-clinical and clinical markets today.
· A biomedical device for lifting, lowering and self-propelled transit of a person having limited use of their legs.
· Unique and customizable electronic medical health record system currently in use by private cardiac practice and SBU medical center.
· A novel biomarker and development of a urine-based diagnostic for prostate cancer.
· An innovative method of growing shellfish, setting marine shoals and growing microalgae in a marine environment for the purpose of feeding shellfish larvae, a biofuel source and/or byproducts such as DHA food.
· Proprietary and unique modular street lighting concept.
· Solar powered distributed micro generation platform that provides electricity, process heating and cooling.
· An online exposition and open forum for the energy and environment business communities, with virtual exhibition space and web-conferencing functions.
Co-hosted by the Center for Biotechnology (CFB), the Clean Energy Business Incubator Program (CEBIP), as well as the Stony Brook University Office of Economic Development and Office of Technology Licensing and Industry Relations (OTLIR), the Innovation Boot Camp / Pre-Seed Workshop was originally created to support entrepreneurial faculty interested in launching a company based on technology they developed and is formally presented by Mark Wilson and Judy Albers, Ph.D of Neworks, LLC. The event was generously supported by Hoffmann & Baron, LLP, the Stony Brook University Office of Economic Development, and NYSERDA. For more information about the Long Island Innovation Boot Camp / Pre-Seed Workshop, please contact Joseph Scaduto (CFB) or David Hamilton (CEBIP).
****************************************************************************************************************************************************************************************************************************************
Stonybrook University Names New Vice President for Research
Benjamin S. Hsiao, PhD, Professor and Chair of the Department of Chemistry at Stony Brook University has been appointed to the position of Vice President for Research at Stony Brook effective May 1, 2012, According to Stony Brook University President Samuel L. Stanley, Jr., “He will be instrumental in helping Stony Brook fully leverage its vital partnerships with Brookhaven National Laboratory and Cold Spring Harbor Laboratory, and I look forward to working with him as Stony Brook's research trajectory continues to rise.” Read full press release.
****************************************************************************************************************************************************************************************************************************************
Technology Innovation Channel Highlights Center for Biotechnology
The Center for Biotechnology was featured on the Technology Innovation Channel (TINC) which showcases cutting-edge and innovative technologies of current interest to the Venture and Private Equity communities. TINC presents the latest technologies being developed at start-ups, academic, government and corporate research facilities worldwide.
Click here to watch the main segment on the Center for Biotechnology
View Additional Segments:
Roadmap to Commercialization featuring Dr. Richard Clark
Bringing Technology to Market - Center for Biotechnology
Featured Technology: LIV Therapy from Dr. Clinton Rubin
Featured Technology: 3-d Virtual Colonoscopy with Dr. Arie Kauffman
Featured Technology: New Cancer Therapeutic with Dr. Paul Bingham
****************************************************************************************************************************************************************************************************************************************
Goddard Scholarship Announced
The Women in Science and Engineering (WISE) Program and the Department of Biomedical Engineering in the College of Engineering and Applied Sciences have recently announced the WISE - Goddard Scholarship. The scholarship is named for its benefactors, Colin Goddard, Ph.D., former CEO of OSI Pharmaceuticals and his wife Amanda. The scholarship will support one active upperclass member of WISE majoring in Biomedical Engineering.
****************************************************************************************************************************************************************************************************************************************
Celmatix Closes Series A Financing Round
Center for Biotechnology client company Celmatix Inc. announced the closing of a Series A financing round led by Topspin Partners. This follows initial funding through seed investment and government grants. Celmatix will use the Series A financing to continue Research and Development for their proposed egg quality diagnostic, FertilArrayTM. Laura Towart Bandak, Celmatix Co-Founder and CEO said, ''This financial endorsement by Topspin will enable us to expand research efforts that are key to rapidly pursuing the commercialization of our revolutionary infertility diagnostic.'' Piraye Yurttas Beim, PhD, Celmatix Co-Founder and CSO added, ''These funds will enable us to continue our studies of the female Fertilome - the region of the human genome that controls egg quality and fertility. A genomic study of this magnitude and scope in the field of reproductive biology is unprecedented.'' www.celmatix.com
****************************************************************************************************************************************************************************************************************************************
The New York Times Health Blog: More Bone (Less Fat) Through Exercise
The New York Times Health Blog recently featured “More Bone (Less Fat) Through Exercise,” which highlights the Center for Biotechnology's Director Dr. Clinton Rubin's research at Stony Brook University.View Article
back to top
|
